NICE nod for Takeda’s Adcetris in advanced stage CTCL by Anna Smith | Mar 22, 2019 | News | 0 Takeda has announced the NICE recommendation of Adcetris for advanced cutaneous T-cell lymphoma. Read More
EC OKs Adcetris for CD30-positive cutaneous T-cell lymphoma by Selina McKee | Jan 23, 2018 | News | 0 The European Commission has extended conditional marketing authorisation for Takeda’s Adcetris to include the treatment of CD30-positive cutaneous T-cell lymphoma (CTCL) following one prior systemic therapy. Read More